Breaking News

You are here » Indian-Commodity  :  Top News  :  Cadila Healthcare gets nod to raise funds

26-May2018

Cadila Healthcare gets nod to raise funds

Cadila Healthcare has received its board's approval to raise funds by issue of Equity Shares/convertible Bonds/Debentures through Qualified Institutional Placement (QIP)/GDR/ ADR, for an aggregate amount up to Rs 10,000 crore. The meeting of the Board of Directors of the company held on May 25, 2018, approved the same.

The company has also received approval to issue Secured/ Unsecured Redeemable Non-Convertible Debentures/ Foreign Currency Bonds on private Placement Basis for an amount up to Rs 3,500 crore in the FY 2017-2018. The Board also approved the issue of Foreign Currency Bond/Foreign Currency Convertible Bonds for an amount up to Rs 5,000 crore.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.


Related News

View all news

Physical rubber prices ruled steady on Saturday

Physical Rubber prices ruled steady on Saturday due to buyer resistance in the market. Spot prices for RSS-4 and RSS-5 variety closed unchanged at Rs 125/ kg and Rs 120.50/ kg respectively.In the futures......

Gold futures trade almost steady on Monday

Gold futures traded almost steady on Monday, with cautious outlook from investors as they eyed on impending report from china showcasing dimmed economic growth to its slowest in 28 years in 2018 in face......

Crude palm oil futures trade in green on rise in demand

Crude palm oil futures traded in green on MCX in line with the firm  trend in Malaysian palm oil prices. Moreover, rise in spot demand from domestic markets coupled with the worries on dip in......

Top News

View all news

Glenmark Pharma recalling 96,240 applicators of its product from US

Glenmark Pharmaceuticals is recalling 96,240 applicators of its product Estradiol vaginal inserts for defective delivery system. The USFDA has termed it as a Class-II recall. The USFDA has classified Class-II......

Infosys hires over 7,600 staff in US

Infosys has hired over 7,600 staff in the US. This hiring is more than three-fourth of its target of recruiting 10,000 American workers. The company is making recruitment from local schools a 'sustained......

SBI to sell 26% stake of SBI payment services

State Bank of India (SBI) is planning to sell 26% stake of its SBI payment services (SPSPL) to Hitachi Payment Services (HPY). After allotment of the shares, SBI shareholding in SPSPL will become 74% from......